GENSIGHT BIOLOGICS S.A.

Profile

Company Names

GENSIGHT BIOLOGICS S.A.

Addresses

74 RUE DU FAUBOURG SAINT-ANTOINE, PARIS, I0 75012

Phone Numbers

01133176217220

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

FRANCE

Total Amount Raised:

$24,985,706.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-07-07 
$24,985,706.00 
$24,985,706.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN-PHILIPPE 
 
COMBAL 
EXECUTIVE OFFICER
GENSIGHT BIOLOGICS S.A.
THOMAS 
 
GIDOIN 
EXECUTIVE OFFICER
GENSIGHT BIOLOGICS S.A.
BERNARD 
 
GILLY 
EXECUTIVE OFFICER, DIRECTOR
KALA PHARMACEUTICALS, INC.   |  GENSIGHT BIOLOGICS S.A.
PETER 
 
GOODFELLOW 
DIRECTOR
PROSENSA HOLDING N.V.   |  GENSIGHT BIOLOGICS S.A.
FLORENT 
 
GROS 
DIRECTOR
VAXIN INC.   |  KANYOS BIO, INC.   |  GENSIGHT BIOLOGICS S.A.   |  ADICET BIO, INC.
GENGHIS 
 
LLOYD-HARRIS 
DIRECTOR
GENSIGHT BIOLOGICS S.A.   |  ABINGWORTH BIOVENTURES VII LP
GUIDO 
 
MAGNI 
DIRECTOR
BIOTIE THERAPIES CORP.   |  GENSIGHT BIOLOGICS S.A.   |  TARVEDA THERAPEUTICS, INC.
DIDIER 
 
PRUNEAU 
EXECUTIVE OFFICER
GENSIGHT BIOLOGICS S.A.
NITZA 
 
THOMASSON 
EXECUTIVE OFFICER
GENSIGHT BIOLOGICS S.A.
MICHAEL 
STEPHEN 
WYZGA 
DIRECTOR
GENSIGHT BIOLOGICS S.A.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-07-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011